MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
In leukemia, diverse fusion proteins involving the MLL gene can drive oncogenic activity. Here, the authors describe a dependency of MLL-leukemia cells on the methyltransferase SETD2 to maintain genomic integrity during leukemia initiation and maintenance.
Guardado en:
Autores principales: | Anna Skucha, Jessica Ebner, Johannes Schmöllerl, Mareike Roth, Thomas Eder, Adrián César-Razquin, Alexey Stukalov, Sarah Vittori, Matthias Muhar, Bin Lu, Martin Aichinger, Julian Jude, André C. Müller, Balázs Győrffy, Christopher R. Vakoc, Peter Valent, Keiryn L. Bennett, Johannes Zuber, Giulio Superti-Furga, Florian Grebien |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c65cecc9bf1145a685881a4d0ac0ba9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safeguarding our soils
Publicado: (2017) -
Structural basis for the target specificity of actin histidine methyltransferase SETD3
por: Shaobo Dai, et al.
Publicado: (2019) -
The histone methyltransferase Setd2 is indispensable for V(D)J recombination
por: Zhongzhong Ji, et al.
Publicado: (2019) -
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
por: Mingdong Lu, et al.
Publicado: (2021) -
Functional dissection of the TBK1 molecular network.
por: Adriana Goncalves, et al.
Publicado: (2011)